Other Species / Isoforms
  CRK (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S40-p
GVFLVRDsstsPGDy
0 15
CRK (human) GVFLVRDsstsPGDy S40-p
CRK iso2 (human) GVFLVRDSSTSPGDY S40
CRK (mouse) GVFLVRDsstSPGDY S40-p
CRK iso3 (mouse) GVFLVRDSSTSPGDY S40
CRK (rat) GVFLVRDssTsPGDY S40-p
CRK (chicken) GTFLVRDSGSIPGDF S40
S41-p
VFLVRDsstsPGDyV
Upstream
Downstream
2 36
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell motility, induced
  • transcription, inhibited
Putative in vivo kinases:
  • PAK1 (human)
Treatment
  • BMS-225975
  • nocodazole
  • P61A6
  • siRNA
view more >
CRK (human) VFLVRDsstsPGDyV S41-p
CRK iso2 (human) VFLVRDSSTSPGDYV S41
CRK (mouse) VFLVRDsstSPGDYV S41-p
CRK iso3 (mouse) VFLVRDSSTSPGDYV S41
CRK (rat) VFLVRDssTsPGDYV S41-p
CRK (chicken) TFLVRDSGSIPGDFV G41
T42-p
FLVRDsstsPGDyVL
0 9
CRK (human) FLVRDsstsPGDyVL T42-p
CRK iso2 (human) FLVRDSSTSPGDYVL T42
CRK (mouse) FLVRDsstSPGDYVL T42-p
CRK iso3 (mouse) FLVRDSSTSPGDYVL T42
CRK (rat) FLVRDssTsPGDYVL T42
CRK (chicken) FLVRDSGSIPGDFVL S42
S43-p
LVRDsstsPGDyVLS
0 3
CRK (human) LVRDsstsPGDyVLS S43-p
CRK iso2 (human) LVRDSSTSPGDYVLS S43
CRK (mouse) LVRDsstSPGDYVLS S43
CRK iso3 (mouse) LVRDSSTSPGDYVLS S43
CRK (rat) LVRDssTsPGDYVLS S43-p
CRK (chicken) LVRDSGSIPGDFVLS I43
Y47-p
sstsPGDyVLSVSEN
0 4
CRK (human) sstsPGDyVLSVSEN Y47-p
CRK iso2 (human) SSTSPGDYVLSVSEN Y47
CRK (mouse) sstSPGDYVLSVSEN Y47
CRK iso3 (mouse) SSTSPGDYVLSVSEN Y47
CRK (rat) ssTsPGDYVLSVSEN Y47
CRK (chicken) SGSIPGDFVLSVSES F47
S74-p
PRPPVPPsPAQPPPG
Upstream
0 23
Treatment
  • nocodazole
CRK (human) PRPPVPPsPAQPPPG S74-p
CRK iso2 (human) PRPPVPPSPAQPPPG S74
CRK (mouse) PRPPVPPsPAQPPPG S74-p
CRK iso3 (mouse) PRPPVPPSPAQPPPG S74
CRK (rat) PRPPVPPSPAQPPPG S74
CRK (chicken) GRRAGGEGPGAPGLN G77
S83-p
AQPPPGVsPsRLRIG
0 8
CRK (human) AQPPPGVsPsRLRIG S83-p
CRK iso2 (human) AQPPPGVSPSRLRIG S83
CRK (mouse) AQPPPGVsPsRLRIG S83-p
CRK iso3 (mouse) AQPPPGVSPSRLRIG S83
CRK (rat) AQPPPGVSPSRLRIG S83
CRK (chicken) GPGAPGLNPTRFRIG N84
S85-p
PPPGVsPsRLRIGDQ
0 7
CRK (human) PPPGVsPsRLRIGDQ S85-p
CRK iso2 (human) PPPGVSPSRLRIGDQ S85
CRK (mouse) PPPGVsPsRLRIGDQ S85-p
CRK iso3 (mouse) PPPGVSPSRLRIGDQ S85
CRK (rat) PPPGVSPSRLRIGDQ S85
CRK (chicken) GAPGLNPTRFRIGDQ T86
S96-p
IGDQEFDsLPALLEF
0 2
CRK (human) IGDQEFDsLPALLEF S96-p
CRK iso2 (human) IGDQEFDSLPALLEF S96
CRK (mouse) IGDQEFDSLPALLEF S96
CRK iso3 (mouse) IGDQEFDSLPALLEF S96
CRK (rat) IGDQEFDSLPALLEF S96
CRK (chicken) IGDQEFDSLPSLLEF S97
Y108-p
LEFYKIHyLDtttLI
0 85
CRK (human) LEFYKIHyLDtttLI Y108-p
CRK iso2 (human) LEFYKIHYLDTTTLI Y108
CRK (mouse) LEFYKIHyLDTTTLI Y108-p
CRK iso3 (mouse) LEFYKIHYLDTTTLI Y108
CRK (rat) LEFYKIHYLDTTTLI Y108
CRK (chicken) LEFYKIHYLDTTTLI Y109
T111-p
YKIHyLDtttLIEPV
0 1
CRK (human) YKIHyLDtttLIEPV T111-p
CRK iso2 (human) YKIHYLDTTTLIEPV T111
CRK (mouse) YKIHyLDTTTLIEPV T111
CRK iso3 (mouse) YKIHYLDTTTLIEPV T111
CRK (rat) YKIHYLDTTTLIEPV T111
CRK (chicken) YKIHYLDTTTLIEPV T112
T112-p
KIHyLDtttLIEPVS
0 4
CRK (human) KIHyLDtttLIEPVS T112-p
CRK iso2 (human) KIHYLDTTTLIEPVS T112
CRK (mouse) KIHyLDTTTLIEPVA T112
CRK iso3 (mouse) KIHYLDTTTLIEPVA T112
CRK (rat) KIHYLDTTTLIEPVS T112
CRK (chicken) KIHYLDTTTLIEPVS T113
T113-p
IHyLDtttLIEPVSR
0 1
CRK (human) IHyLDtttLIEPVSR T113-p
CRK iso2 (human) IHYLDTTTLIEPVSR T113
CRK (mouse) IHyLDTTTLIEPVAR T113
CRK iso3 (mouse) IHYLDTTTLIEPVAR T113
CRK (rat) IHYLDTTTLIEPVSR T113
CRK (chicken) IHYLDTTTLIEPVSR T114
S121-p
LIEPVSRsrQGsGVI
0 4
CRK (human) LIEPVSRsrQGsGVI S121-p
CRK iso2 (human) LIEPVSRSRQGSGVI S121
CRK (mouse) LIEPVARSRQGsGVI S121
CRK iso3 (mouse) LIEPVARSRQGSGVI S121
CRK (rat) LIEPVSRsRQGsGVI S121-p
CRK (chicken) LIEPVSRSRQNSGVI S122
R122-m1
IEPVSRsrQGsGVIL
0 1
CRK (human) IEPVSRsrQGsGVIL R122-m1
CRK iso2 (human) IEPVSRSRQGSGVIL R122
CRK (mouse) IEPVARSRQGsGVIL R122
CRK iso3 (mouse) IEPVARSRQGSGVIL R122
CRK (rat) IEPVSRsRQGsGVIL R122
CRK (chicken) IEPVSRSRQNSGVIL R123
S125-p
VSRsrQGsGVILRQE
Upstream
0 23
Treatment
  • ischemia
CRK (human) VSRsrQGsGVILRQE S125-p
CRK iso2 (human) VSRSRQGSGVILRQE S125
CRK (mouse) VARSRQGsGVILRQE S125-p
CRK iso3 (mouse) VARSRQGSGVILRQE S125
CRK (rat) VSRsRQGsGVILRQE S125-p
CRK (chicken) VSRSRQNSGVILRQE S126
Y136-p
LRQEEAEyVRALFDF
Upstream
0 88
Treatment
  • gefitinib
CRK (human) LRQEEAEyVRALFDF Y136-p
CRK iso2 (human) LRQEEAEYVRALFDF Y136
CRK (mouse) LRQEEAEyVRALFDF Y136-p
CRK iso3 (mouse) LRQEEAEYVRALFDF Y136
CRK (rat) LRQEEAEYVRALFDF Y136
CRK (chicken) LRQEEVEYVRALFDF Y137
K154-ac
DEEDLPFkKGDILRI
0 1
CRK (human) DEEDLPFkKGDILRI K154-ac
CRK iso2 (human) DEEDLPFKKGDILRI K154
CRK (mouse) DEEDLPFKKGDILRI K154
CRK iso3 (mouse) DEEDLPFKKGDILRI K154
CRK (rat) DEEDLPFKKGDILRI K154
CRK (chicken) DDEDLPFKKGDILKI K155
S175-p
QWWNAEDsEGKRGMI
0 1
CRK (human) QWWNAEDsEGKRGMI S175-p
CRK iso2 (human) QWWNAEDSEGKRGMI S175
CRK (mouse) QWWNAEDSEGKRGMI S175
CRK iso3 (mouse) QWWNAEDSEGKRGMI S175
CRK (rat) QWWNAEDSEGKRGMI S175
CRK (chicken) QWWNAEDMDGKRGMI M176
Y190-p
PVPYVEKyRPAsAsV
0 8
CRK (human) PVPYVEKyRPAsAsV Y190-p
CRK iso2 (human) PVPYVEKYRPAsAsV Y190
CRK (mouse) PVPYVEKYRPAsASV Y190
CRK iso3 (mouse) PVPYVEKYRPAsASV Y190
CRK (rat) PVPYVEKYRPASASV Y190
CRK (chicken) PVPYVEKCRPSSASV C191
S194-p
VEKyRPAsAsVsALI
0 21
CRK (human) VEKyRPAsAsVsALI S194-p
CRK iso2 (human) VEKYRPAsAsVSALI S194-p
CRK (mouse) VEKYRPAsASVsALI S194-p
CRK iso3 (mouse) VEKYRPAsASVSALI S194-p
CRK (rat) VEKYRPASASVSALI S194
CRK (chicken) VEKCRPSSASVSTLT S195
S196-p
KyRPAsAsVsALIGG
0 8
CRK (human) KyRPAsAsVsALIGG S196-p
CRK iso2 (human) KYRPAsAsVSALIGG S196-p
CRK (mouse) KYRPAsASVsALIGG S196
CRK iso3 (mouse) KYRPAsASVSALIGG S196
CRK (rat) KYRPASASVSALIGG S196
CRK (chicken) KCRPSSASVSTLTGG S197
S198-p
RPAsAsVsALIGGNQ
0 5
CRK (human) RPAsAsVsALIGGNQ S198-p
CRK iso2 (human) RPAsAsVSALIGGR_ S198
CRK (mouse) RPAsASVsALIGGNQ S198-p
CRK iso3 (mouse) RPAsASVSALIGGR_ S198
CRK (rat) RPASASVSALIGGNQ S198
CRK (chicken) RPSSASVSTLTGGNQ S199
S208-p
IGGNQEGsHPQPLGG
0 8
CRK (human) IGGNQEGsHPQPLGG S208-p
CRK iso2 (human) gap -
CRK (mouse) IGGNQEGsHPQPLGG S208-p
CRK iso3 (mouse) gap -
CRK (rat) IGGNQEGSHPQPLGG S208
CRK (chicken) TGGNQDSSHPQPLGG S209
Y221-p
GGPEPGPyAQPsVNt
Upstream
Downstream
25 1178
CRK (human)
Y221-p
CRK (mouse)
Y221-p
CRK (rat)
Y221-p
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, induced
  • cell adhesion, altered
  • cell adhesion, inhibited
Kinase, in vitro:
  • Abl (human)
  • Arg (human)
Phosphatases, in vitro:
  • PTP1B (human)
Putative in vivo kinases:
  • Abl (human)
Putative upstream phosphatases:
  • PTP1B (human)
  • SHP-1 (human)
Treatment
  • BAPTA-AM
  • cholecystokinin
  • cytochalasin_D
  • EGF
  • ephrin_A1
  • fibronectin
  • gefitinib
  • GF109203X
  • H2O2
  • HGF
  • imatinib
  • LY294002
  • nilotinib
  • NSC-87877
  • PDGF
  • Rosmarinic acid
  • rotenone
  • serum_withdrawal
  • sorbitol
  • Su11274
  • thapsigargin
  • vanadate
  • VEGF
  • wortmannin
view more >
CRK (human) GGPEPGPyAQPsVNt Y221-p
CRK iso2 (human) gap -
CRK (mouse) GGPEPGPyAQPsVNt Y221-p
CRK iso3 (mouse) gap -
CRK (rat) GGPEPGPyAQPsVNt Y221-p
CRK (chicken) GGPEPGPyAQPSINT Y222-p
S225-p
PGPyAQPsVNtPLPN
0 423
CRK (human) PGPyAQPsVNtPLPN S225-p
CRK iso2 (human) gap -
CRK (mouse) PGPyAQPsVNtPLPN S225-p
CRK iso3 (mouse) gap -
CRK (rat) PGPyAQPsVNtPLPN S225-p
CRK (chicken) PGPyAQPSINTPLPN S226
T228-p
yAQPsVNtPLPNLQN
0 53
CRK (human) yAQPsVNtPLPNLQN T228-p
CRK iso2 (human) gap -
CRK (mouse) yAQPsVNtPLPNLQN T228-p
CRK iso3 (mouse) gap -
CRK (rat) yAQPsVNtPLPNLQN T228-p
CRK (chicken) yAQPSINTPLPNLQN T229
Y239-p
NLQNGPIyARVIQKR
Upstream
Downstream
2 273
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • Abl (human)
Putative in vivo kinases:
  • Abl (human)
Treatment
  • imatinib
  • PDGF
CRK (human) NLQNGPIyARVIQKR Y239-p
CRK iso2 (human) gap -
CRK (mouse) NLQNGPIyARVIQKR Y239-p
CRK iso3 (mouse) gap -
CRK (rat) NLQNGPIYARVIQKR Y239
CRK (chicken) NLQNGPFyARVIQKR Y240-p
Y251-p
QKRVPNAyDktALAL
Upstream
Downstream
3 318
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell adhesion, inhibited
  • cell motility, induced
Kinase, in vitro:
  • Abl (human)
Putative in vivo kinases:
  • Abl (human)
Regulatory protein:
  • Abi-1 (human)
Treatment
  • EGF
  • imatinib
CRK (human) QKRVPNAyDktALAL Y251-p
CRK iso2 (human) gap -
CRK (mouse) QKRVPNAyDKTALAL Y251-p
CRK iso3 (mouse) gap -
CRK (rat) QKRVPNAyDKTALAL Y251-p
CRK (chicken) QKRVPNAYDKTALAL Y252
K253-ac
RVPNAyDktALALEV
0 2
CRK (human) RVPNAyDktALALEV K253-ac
CRK iso2 (human) gap -
CRK (mouse) RVPNAyDKTALALEV K253
CRK iso3 (mouse) gap -
CRK (rat) RVPNAyDKTALALEV K253
CRK (chicken) RVPNAYDKTALALEV K254
T254-p
VPNAyDktALALEVG
0 2
CRK (human) VPNAyDktALALEVG T254-p
CRK iso2 (human) gap -
CRK (mouse) VPNAyDKTALALEVG T254
CRK iso3 (mouse) gap -
CRK (rat) VPNAyDKTALALEVG T254
CRK (chicken) VPNAYDKTALALEVG T255
S304-p
QNPDEDFs_______
0 3
CRK (human) QNPDEDFs_______ S304-p
CRK iso2 (human) gap -
CRK (mouse) QNPDEDFS_______ S304
CRK iso3 (mouse) gap -
CRK (rat) QNPEEDFs_______ S304-p
CRK (chicken) QNPDEDFS_______ S305